Method Of Inhibiting Biomaterial-induced Procoagulant Activity Using Complement Inhibitors

Abstract

Methods for reducing or eliminating biomaterial-induced procoagulant activity in blood subjected to extracorporeal treatment that exposes the blood to the biomaterial are disclosed. The methods involve treatment of the blood, or the extracorporeal biomaterial, or both, with a complement inhibitor to inhibit C5a/C5aR-mediated tissue factor formation in the blood.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 3, 2011
  • Application: Sep 29, 2009
    US US 200913121396 A
  • Priority: Sep 29, 2009
    US US 200913121396 A
  • Priority: Sep 29, 2009
    US US 2009/0058745 W
  • Priority: Sep 30, 2008
    US US 10145308 P

Download Citation


Sign in to the Lens

Feedback